Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Study of Renal Denervation in Patients With Treatment Resistant Hypertension (PaCE)

This study has been terminated.
(Manufacturer updated device technology.)
Sponsor:
Collaborators:
Medtronic
MaRS Excellence in Clinical Innovation and Technology Evaluation (EXCITE)
Information provided by (Responsible Party):
Dr. Harindra Wijeysundera, Sunnybrook Health Sciences Centre
ClinicalTrials.gov Identifier:
NCT01895140
First received: June 26, 2013
Last updated: October 10, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2014
  Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)